amyloid-beta peptide 40/42 in CSF (Lumipulse G)
Jump to navigation
Jump to search
Notes
- used to identify older individuals with preclinical Alzheimer's disease[1]
More general terms
Additional terms
Components
References
- ↑ 1.0 1.1 George J Driving Patterns Pinpoint Early Alzheimer's Disease. Subtle shifts in on-road behavior suggest GPS-based biomarkers may have merit. MedPage Today July 30, 2021 https://www.medpagetoday.com/meetingcoverage/aaic/93840
- ↑ 2.0 2.1 George J Early Alzheimer's Test Gets FDA Nod First in vitro diagnostic to detect amyloid in early disease setting MedPage Today May 5, 2022 https://www.medpagetoday.com/neurology/alzheimersdisease/98558
FDA News Release. May 4, 2022 FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer's Disease. https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-new-test-improve-diagnosis-alzheimers-disease